Stay updated on Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page
- CheckyesterdayChange DetectedThe record history shows a new revision entry (v3.5.4) and removes the previous revision (v3.5.3), updating the version sequence in the history.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page’s platform revision/version indicator was updated from **v3.5.2** to **v3.5.3**, reflecting a general software release with no apparent change to the displayed clinical trial record details.SummaryDifference0.1%

- Check29 days agoChange DetectedA new revision entry, v3.5.2, was added to the history and the older v3.5.0 entry was removed.SummaryDifference0.1%

- Check58 days agoChange DetectedAdded version v3.5.0 to the history and removed version v3.4.3.SummaryDifference0.1%

- Check65 days agoChange DetectedA new Revision: v3.4.3 was added and Revision: v3.4.2 was removed from the page history.SummaryDifference0.1%

- Check94 days agoChange DetectedAdded a new revision entry (v3.4.2) and removed an older notice about government funding/operating status (v3.4.1) from the history page.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page.